Literature DB >> 20057366

Longitudinal adaptations to very low-carbohydrate weight-reduction diet in obese rats: body composition and glucose tolerance.

Kathleen V Axen1, Kenneth Axen.   

Abstract

Longitudinal effects of a very low-carbohydrate (VLC) and a calorie-matched high-carbohydrate (HC) weight reduction diet were compared in dietary obese Sprague-Dawley rats exhibiting impaired glucose tolerance and insulin resistance. Obese rats were divided into weight-matched groups: (i) VLC rats consumed an energy-restricted 5% carbohydrate, 60% fat diet for 8 weeks, (ii) HC rats consumed an isocaloric 60% carbohydrate, 15% fat diet, and (iii) HF rats consumed a high-fat diet ad libitum. HC and VLC rats showed similar reductions in body fat and hepatic lipid at the midpoint of the weight-reduction program, indicating effects due to energy deficit. At the end point, however, HC rats showed greater reductions in total and percent body fat, hepatic lipid and intramuscular lipid than did VLC rats, suggesting that diet composition induced changes in the relative efficiencies of the HC and VLC diets over time. HC rats showed marked improvement in glucose tolerance at the midpoint and end point, whereas VLC rats showed no improvement. Impaired glucose tolerance in VLC rats at the end point was due to insulin resistance and an attenuated insulin secretory response. Glucose tolerance in energy-restricted rats correlated negatively with hepatic and intramuscular lipid levels, but not visceral or total fat mass. These findings demonstrate that adaptations to diet composition eventually enabled HC rats to lose more body fat than VLC rats even though energy intakes were equal, and suggest that the elevated levels of hepatic and intramuscular lipid associated with VLC diets might predispose to insulin resistance and impaired glucose tolerance despite weight loss.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20057366     DOI: 10.1038/oby.2009.466

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

Review 1.  Biology's response to dieting: the impetus for weight regain.

Authors:  Paul S Maclean; Audrey Bergouignan; Marc-Andre Cornier; Matthew R Jackman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

2.  Dietary macronutrient composition affects β cell responsiveness but not insulin sensitivity.

Authors:  Laura Lee Goree; Paula Chandler-Laney; Amy C Ellis; Krista Casazza; Wesley M Granger; Barbara A Gower
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

3.  Impact of high-fat, low-carbohydrate diet on myocardial substrate oxidation, insulin sensitivity, and cardiac function after ischemia-reperfusion.

Authors:  Jian Liu; Peipei Wang; Samuel L Douglas; Joshua M Tate; Simon Sham; Steven G Lloyd
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

4.  The long-term ingestion of a diet high in extra virgin olive oil produces obesity and insulin resistance but protects endothelial function in rats: a preliminary study.

Authors:  Hady Keita; Eduardo Ramírez-San Juan; Norma Paniagua-Castro; Leticia Garduño-Siciliano; Lucía Quevedo
Journal:  Diabetol Metab Syndr       Date:  2013-09-18       Impact factor: 3.320

5.  Benefits of resistance training on body composition and glucose clearance are inhibited by long-term low carbohydrate diet in rats.

Authors:  Uliana Sbeguen Stotzer; Graziéle Fernanda Deriggi Pisani; Gustavo Henrique Rigo Canevazzi; Gilberto Eiji Shiguemoto; Ana Cláudia Garcia de Oliveira Duarte; Sergio Eduardo de Andrade Perez; Heloisa Sobreiro Selistre-de-Araújo
Journal:  PLoS One       Date:  2018-12-07       Impact factor: 3.240

6.  Very low-carbohydrate, high-fat, weight reduction diet decreases hepatic gene response to glucose in obese rats.

Authors:  Kathleen V Axen; Marianna A Harper; Yu Fu Kuo; Kenneth Axen
Journal:  Nutr Metab (Lond)       Date:  2018-07-31       Impact factor: 4.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.